ZOM News and Press, Zomedica Pharmaceuticals Corp. From 12/15/21

ANN ARBOR, MI / ACCESSWIRE / December 15, 2021 / Zomedica Corp. (NYSE American:ZOM), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, announced today that Larry Heaton, Chief Executive Officer, will present a company overview at t...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Penny stocks are still a hot topic among retail traders and we’re covering some of the top ones to watch Wednesday that are on the move. Source: John Brueske/Shutterstock.com But before that, I do have to war...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips I’ve felt that Zomedica (NYSEAMERICAN: ZOM ) stock was miscast as a meme play. Source: Postmodern Studio / Shutterstock.com The stock checks off some of the boxes for what constituted a meme stock, ...

Shares of Zomedica (NYSEMKT: ZOM) were sinking 14.8% lower for the week as of the market close on Thursday, according to data from S&P Global Market Intelligence . The reason behind the decline goes back into the previous week, when Zomedica announced its third-quarter ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips As has been the case for several months, Zomedica (NYSEAMERICAN: ZOM ) continues to tread water. ZOM stock, a pet diagnostics play and reputed meme stock, has struggled to bounce back after big declines last spring. ...

3 Penny Stocks to Add to Next Week’s Watchlist With another week of trading penny stocks and blue chips set to begin, investors are hopeful about the future. Although high inflation rates and uncertainty about the future have clouded several days of trading, overall, we’re...

Zomedica (NYSE:ZOM) has lost ~5.5% in the post-market after the company reported Q3 2021 financials that indicated rising net loss amid a surge in selling, general and administrative expenses (SG&A) for the quarter. While the animal health company recorded $22,514 in revenu...

Zomedica (NYSE:ZOM): Q3 GAAP EPS of -$0.01. Revenue of $22.51K Shares -0.93%. Press Release Zomedica had cash and cash equivalents of approximately $271.4 million as of September 30, 2021, compared to approximately $52 as of September 30, 2020. For further details see: Zomedica reports ...

ANN ARBOR, MI / ACCESSWIRE / November 12, 2021 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or "Company"), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today reported consolidated financial results for the three and nine months ended Septem...

MSCI will be including total 112 companies  including  Zomedica (NYSE:ZOM), Clovis Oncology (NASDAQ:CLOV), 22nd Century (NASDAQ:XXII), Omeros (NASDAQ:OMER) and Verastem (NASDAQ:VSTM) in its MSCI US Micro Cap Index as a part of Semi-Annual Index Review. MSCI excluded a...